NASDAQ:ILMN - Illumina Stock Price, Price Target & More

$245.84 -4.16 (-1.66 %)

(As of 04/19/2018 04:00 PM ET)

Previous Close$250.00

Today's Range$244.01 - $249.77

52-Week Range$167.98 - $256.64

Volume889,261 shs

Average Volume863,726 shs

Market Capitalization$36.46 billion

P/E Ratio61.46

Dividend YieldN/A

Beta0.89

About Illumina (NASDAQ:ILMN)

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing by synthesis technology that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, agrigenomics, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Receive ILMN News and Ratings via Email

Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments

Sub-IndustryLife Sciences Tools & Services

SectorMedical

SymbolNASDAQ:ILMN

CUSIP45232710

Webwww.illumina.com

Phone858-202-4500

Debt

Debt-to-Equity Ratio0.43%

Current Ratio3.99%

Quick Ratio3.55%

Price-To-Earnings

Trailing P/E Ratio61.46

Forward P/E Ratio53.44

P/E Growth3.31

Sales & Book Value

Annual Sales$2.75 billion

Price / Sales13.11

Cash Flow$5.2654 per share

Price / Cash46.69

Book Value$18.83 per share

Price / Book13.06

Profitability

EPS (Most Recent Fiscal Year)$4.00

Net Income$726 million

Net Margins26.56%

Return on Equity21.71%

Return on Assets11.94%

Miscellaneous

Employees6,200

Outstanding Shares146,750,000

How to Become a New Pot Stock Millionaire

Illumina (NASDAQ:ILMN) Frequently Asked Questions

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina (NASDAQ:ILMN) posted its quarterly earnings results on Tuesday, January, 30th. The life sciences company reported $1.44 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.22 by $0.22. The life sciences company had revenue of $778 million for the quarter, compared to analysts' expectations of $752.04 million. Illumina had a return on equity of 21.71% and a net margin of 26.56%. Illumina's quarterly revenue was up 25.7% on a year-over-year basis. During the same period last year, the firm earned $0.85 earnings per share. View Illumina's Earnings History.

When is Illumina's next earnings date?

Illumina is scheduled to release their next quarterly earnings announcement on Tuesday, April, 24th 2018. View Earnings Estimates for Illumina.

What guidance has Illumina issued on next quarter's earnings?

Illumina updated its FY18 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of $4.50-4.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.58. The company issued revenue guidance of $3.10-3.13 billion, compared to the consensus revenue estimate of $3.13 billion.

What price target have analysts set for ILMN?

20 analysts have issued twelve-month price objectives for Illumina's shares. Their predictions range from $170.00 to $277.00. On average, they anticipate Illumina's share price to reach $242.9412 in the next year. View Analyst Ratings for Illumina.

What are Wall Street analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:

1. According to Zacks Investment Research, "In the last three months, Illumina outperformed its industry. The company’s recent strategic collaborations are expected to expand its product portfolio. This apart an improving margin scenario should also instill confidence on the stock. Currently, Illumina is focusing on product innovation through research and development as well, which is evident from the launch of iSeq 100 Sequencing System recently. Post a promising fourth-quarter show, we expect Illumina to maintain its growth momentum on continued uptake of sequencing consumables, instruments and microarray portfolios. On the flip side, the company is operating in a tough competitive landscape which is a concern. Further, the stock looks a bit overvalued at the moment." (4/16/2018)
2. Canaccord Genuity analysts commented, "Shipments to China grew +16% and we believe China is likely to be a double-digit grower for ILMN over the next several years, driven by the Chinese Precision Medicine Initiative," (8/7/2017)

Who are some of Illumina's key competitors?

Some companies that are related to Illumina include Agilent Technologies (A), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Integra lifesciences (IART), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Pacific Biosciences (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), HTG Molecular Diagnostics (HTGM), pSivida (EYPT) and Precipio (PRPO).

Who are Illumina's key executives?

Illumina's management team includes the folowing people:

Mr. Jay T. Flatley, Exec. Chairman (Age 65)
Mr. Francis A. deSouza, CEO, Pres & Director (Age 47)
Mr. Omead Ostadan, Exec. VP of Operations, Products and Strategy (Age 46)
Dr. Mostafa Ronaghi Ph.D., Chief Technology Officer and Sr. VP (Age 49)
Mr. Marc A. Stapley, Chief Admin. Officer and Exec. VP (Age 48)

Has Illumina been receiving favorable news coverage?

News articles about ILMN stock have been trending somewhat positive on Thursday, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Illumina earned a news impact score of 0.24 on Accern's scale. They also gave media headlines about the life sciences company an impact score of 45.65 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Illumina's major shareholders?

Illumina's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BAILLIE GIFFORD & COMPANY (12.16%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

How do I buy shares of Illumina?

Shares of ILMN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of ILMN stock can currently be purchased for approximately $245.84.

How big of a company is Illumina?

Illumina has a market capitalization of $36.46 billion and generates $2.75 billion in revenue each year. The life sciences company earns $726 million in net income (profit) each year or $4.00 on an earnings per share basis. Illumina employs 6,200 workers across the globe.

How can I contact Illumina?

Illumina's mailing address is 5200 ILLUMINA WAY, SAN DIEGO CA, 92122. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]

MarketBeat Community Rating for Illumina (ILMN)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		734 (Vote Outperform)
Underperform Votes:		722 (Vote Underperform)
Total Votes:		1,456

MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe ILMN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ILMN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Illumina (NASDAQ:ILMN) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

20 Wall Street analysts have issued ratings and price targets for Illumina in the last 12 months. Their average twelve-month price target is $242.9412, suggesting that the stock has a possible downside of 1.18%. The high price target for ILMN is $277.00 and the low price target for ILMN is $170.00. There are currently 1 sell rating, 6 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Hold
Consensus Rating Score:	2.60	2.60	2.52	2.42
Ratings Breakdown:	1 Sell Rating(s) 6 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 6 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 8 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 7 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$242.9412	$242.1765	$218.50	$188.6471
Price Target Upside:	1.18% downside	9.99% upside	9.49% downside	8.73% downside

Illumina (NASDAQ:ILMN) Consensus Price Target History

Price Target History for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/11/2018	Morgan Stanley	Boost Price Target	Underweight -> Underweight	$157.00 -> $170.00	Low
2/5/2018	Citigroup	Upgrade	Neutral -> Buy	$260.00 -> $275.00	High
1/31/2018	Barclays	Boost Price Target	Equal Weight -> Equal Weight	$200.00 -> $215.00	Medium
1/31/2018	Leerink Swann	Boost Price Target	Outperform -> Outperform	$250.00 -> $276.00	High
1/31/2018	Canaccord Genuity	Reiterated Rating	Buy	$255.00 -> $265.00	High
1/31/2018	First Analysis	Upgrade	Equal Weight -> Overweight	$277.00	High
1/22/2018	Cowen	Boost Price Target	Outperform	$250.00 -> $275.00	Low
1/16/2018	BTIG Research	Reiterated Rating	Hold		Low
1/16/2018	Deutsche Bank	Set Price Target	Buy	$275.00	Medium
1/9/2018	Wells Fargo	Reiterated Rating	Outperform -> Positive	$250.00 -> $260.00	High
1/9/2018	Piper Jaffray	Reiterated Rating	Buy	$269.00	N/A
1/5/2018	William Blair	Downgrade	Outperform -> Market Perform		Medium
1/3/2018	Evercore ISI	Initiated Coverage	Outperform	$250.00	Low
10/25/2017	Bank of America	Boost Price Target	Buy	$215.00 -> $240.00	N/A
10/25/2017	Robert W. Baird	Upgrade	Neutral -> Outperform	$184.00 -> $228.00	N/A
10/23/2017	Janney Montgomery Scott	Upgrade	Sell -> Neutral		N/A
9/26/2017	Goldman Sachs	Reiterated Rating	Neutral -> Neutral	$200.00	Low
9/13/2017	Argus	Boost Price Target	Buy	$205.00 -> $235.00	Low
8/2/2017	JPMorgan Chase	Reiterated Rating	Overweight	$250.00	High
4/26/2017	Cantor Fitzgerald	Boost Price Target	Neutral -> Neutral	$155.00 -> $170.00	High
2/1/2017	UBS	Boost Price Target	Buy	$180.00 -> $185.00	N/A
1/6/2017	CL King	Upgrade	Neutral -> Buy		N/A
7/27/2016	Mizuho	Boost Price Target	Neutral	$138.00 -> $148.00	N/A
5/4/2016	Stifel Nicolaus	Reiterated Rating	Buy	$215.00 -> $160.00	N/A
5/3/2016	Nomura	Lower Price Target	Buy	$210.00 -> $180.00	N/A
4/22/2016	Avondale Partners	Reiterated Rating	Market Perform	$175.00 -> $160.00	N/A

(Data available from 4/19/2016 forward)

Illumina (NASDAQ:ILMN) Earnings History and Estimates Chart

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Earnings Estimates

2018 EPS Consensus Estimate: $4.59
2019 EPS Consensus Estimate: $5.19

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$0.88	$1.09	$1.00
Q2 2018	3	$1.06	$1.10	$1.07
Q3 2018	3	$1.14	$1.26	$1.20
Q4 2018	2	$1.25	$1.37	$1.31
Q1 2019	2	$1.03	$1.19	$1.11
Q2 2019	2	$1.20	$1.22	$1.21
Q3 2019	2	$1.35	$1.43	$1.39
Q4 2019	2	$1.41	$1.54	$1.48

Illumina (NASDAQ ILMN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/23/2018		$1.04					N/A
1/30/2018	Q4 2017	$1.22	$1.44	$752.04 million	$778.00 million	View	Listen
10/24/2017	Q3 2017	$0.99	$1.11	$692.77 million	$714.00 million	View	N/A
8/1/2017	Q2 2017	$0.68	$0.82	$642.38 million	$662.00 million	View	Listen
4/25/2017	Q1 2017	$0.64	$0.64	$590.51 million	$598.00 million	View	N/A
1/31/2017	Q416	$0.82	$0.85	$612.50 million	$619.00 million	View	Listen
11/1/2016	Q316	$0.87	$0.97	$628.06 million	$607.00 million	View	Listen
7/26/2016	Q2	$0.73	$0.86	$31.91 million	$600.00 million	View	Listen
5/3/2016	Q1	$0.74	$0.71	$596.33 million	$572.00 million	View	Listen
2/2/2016	Q415	$0.82	$0.81	$576.39 million	$591.50 million	View	Listen
10/20/2015	Q315	$0.79	$0.80	$568.60 million	$550.00 million	View	Listen
7/21/2015	Q215	$0.77	$0.80	$541.05 million	$539.00 million	View	Listen
4/21/2015	Q115	$0.72	$0.91	$524.35 million	$539.00 million	View	Listen
1/27/2015	Q414	$0.78	$0.87	$503.83 million	$512.00 million	View	Listen
10/20/2014	Q314	$0.56	$0.77	$451.20 million	$481.00 million	View	Listen
7/23/2014	Q214	$0.51	$0.57	$426.50 million	$448.00 million	View	Listen
4/22/2014	Q114	$0.44	$0.53	$391.50 million	$421.00 million	View	Listen
1/28/2014	Q413	$0.44	$0.45	$382.06 million	$387.00 million	View	Listen
10/21/2013	Q313	$0.40	$0.45	$343.42 million	$357.00 million	View	Listen
7/23/2013	Q2 2013	$0.40	$0.43	$331.77 million	$346.09 million	View	Listen
4/22/2013	Q1 2013	$0.39	$0.46	$310.64 million	$330.96 million	View	Listen
1/28/2013	Q4 2012	$0.41	$0.42	$303.13 million	$309.30 million	View	Listen
10/23/2012		$0.39	$0.41			View	N/A
7/24/2012		$0.36	$0.40			View	N/A
4/23/2012		$0.32	$0.36			View	N/A
2/7/2012		$0.30	$0.35			View	N/A
10/25/2011		$0.23	$0.22			View	N/A
7/26/2011	Q2 2011	$0.36	$0.38			View	N/A
4/26/2011		$0.31	$0.35			View	N/A
2/8/2011		$0.29	$0.29			View	N/A
10/26/2010	Q3 2010	$0.24	$0.30			View	N/A
7/27/2010	Q2 2010	$0.23	$0.26			View	N/A
4/28/2010	Q1 2010	$0.19	$0.21			View	N/A
2/4/2010	Q4 2009	$0.19	$0.20			View	N/A
10/27/2009	Q3 2009	$0.20	$0.17			View	N/A
7/21/2009	Q2 2009	$0.18	$0.18			View	N/A
4/21/2009	Q1 2009	$0.19	$0.19			View	N/A
2/3/2009	Q4 2008	$0.17	$0.24			View	N/A
10/21/2008	Q3 2008	$0.17	$0.17			View	N/A
7/22/2008	Q2 2008	$0.14	$0.15			View	N/A
4/22/2008	Q1 2008	$0.12	$0.12			View	N/A
2/4/2008	Q4 2007	$0.12	$0.15			View	N/A

(Earnings results data provided by Zacks Investment Research)

Illumina (NASDAQ:ILMN) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Illumina (NASDAQ ILMN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.54%
Institutional Ownership Percentage: 91.68%

Insider Trading History for Illumina (NASDAQ:ILMN)

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/12/2018	Oene Mark Van	SVP	Sell	1,400	$238.48	$333,872.00	12,217
4/3/2018	Charles Dadswell	SVP	Sell	116	$230.91	$26,785.56	7,875
4/2/2018	A Blaine Bowman	Director	Sell	3,000	$230.13	$690,390.00	19,868
3/15/2018	Frances Arnold	Director	Sell	250	$252.26	$63,065.00	10,189
3/8/2018	Frances Arnold	Director	Sell	250	$241.50	$60,375.00	10,439
3/5/2018	Charles Dadswell	SVP	Sell	145	$227.17	$32,939.65	7,991
3/5/2018	Karin Eastham	Director	Sell	2,000	$229.37	$458,740.00	15,288
3/2/2018	Omead Ostadan	EVP	Sell	1,329	$222.66	$295,915.14	29,392
2/28/2018	Robert S Epstein	Director	Sell	250	$231.25	$57,812.50	7,088
2/16/2018	Oene Mark Van	SVP	Sell	1,408	$228.85	$322,220.80	15,760
2/6/2018	Marc Stapley	EVP	Sell	2,000	$216.87	$433,740.00	27,952
2/5/2018	Charles Dadswell	SVP	Sell	1,610	$221.45	$356,534.50	5,581
2/1/2018	A Blaine Bowman	Director	Sell	3,000	$230.82	$692,460.00	19,868
1/29/2018	Robert S Epstein	Director	Sell	1,250	$244.18	$305,225.00	8,588
1/17/2018	Marc Stapley	EVP	Sell	2,000	$242.33	$484,660.00	29,815
1/16/2018	Jay T Flatley	Director	Sell	15,000	$243.72	$3,655,800.00	449,201
1/3/2018	Charles Dadswell	SVP	Sell	145	$224.50	$32,552.50	7,411
1/2/2018	Jay T Flatley	Director	Sell	20,000	$223.40	$4,468,000.00	463,436
12/29/2017	Robert S Epstein	Director	Sell	1,250	$217.38	$271,725.00
12/29/2017	Robert S Epstein	Director	Sell	1,250	$217.38	$271,725.00	8,838
12/19/2017	Jay T Flatley	Director	Sell	20,000	$215.48	$4,309,600.00	480,476
12/5/2017	Jay T Flatley	Director	Sell	20,000	$212.55	$4,251,000.00	505,980
12/4/2017	Charles Dadswell	SVP	Sell	145	$225.33	$32,672.85	6,388
12/4/2017	Marc Stapley	EVP	Sell	2,000	$219.88	$439,760.00	29,198
12/1/2017	Omead Ostadan	EVP	Sell	3,540	$226.91	$803,261.40	26,827
12/1/2017	Robert S Epstein	Director	Sell	1,250	$226.55	$283,187.50	9,088
11/21/2017	Jay T Flatley	Director	Sell	20,000	$211.35	$4,227,000.00	531,717
11/15/2017	Marc Stapley	EVP	Sell	2,000	$205.48	$410,960.00	30,370
11/15/2017	Oene Mark Van	SVP	Sell	1,250	$207.76	$259,700.00	11,691
11/13/2017	Oene Mark Van	SVP	Sell	1,232	$207.78	$255,984.96	11,691
11/7/2017	Jay T Flatley	Director	Sell	20,000	$210.59	$4,211,800.00	536,717
11/3/2017	Charles Dadswell	SVP	Sell	1,609	$207.88	$334,478.92	7,217
10/26/2017	Marc Stapley	EVP	Sell	2,000	$206.88	$413,760.00	34,579
10/24/2017	Jay T Flatley	Director	Sell	20,000	$210.43	$4,208,600.00	539,176
10/12/2017	Oene Mark Van	SVP	Sell	1,250	$207.21	$259,012.50
10/10/2017	Jay T Flatley	Director	Sell	20,000	$203.27	$4,065,400.00
10/3/2017	Charles Dadswell	SVP	Sell	145	$202.23	$29,323.35
9/26/2017	Jay T Flatley	Director	Sell	20,000	$200.16	$4,003,200.00	539,176
9/12/2017	Jay T Flatley	Director	Sell	20,000	$211.11	$4,222,200.00	539,176
9/12/2017	Oene Mark Van	SVP	Sell	9,729	$211.33	$2,056,029.57	24,908
9/7/2017	Mostafa Ronaghi	SVP	Sell	20,000	$210.00	$4,200,000.00	86,725
9/5/2017	Charles Dadswell	SVP	Sell	145	$205.71	$29,827.95
9/5/2017	Marc Stapley	EVP	Sell	2,000	$205.93	$411,860.00	36,179
8/31/2017	Michel Bouchard	Insider	Sell	5,390	$202.11	$1,089,372.90	15,161
8/30/2017	Michel Bouchard	CAO	Sell	616	$200.00	$123,200.00	15,161
8/29/2017	Jay T Flatley	Director	Sell	22,540	$195.21	$4,400,033.40	539,176
8/28/2017	Jay T Flatley	Director	Sell	2,540	$197.39	$501,370.60	539,176
8/15/2017	Jay T Flatley	Director	Sell	20,000	$194.73	$3,894,600.00	539,176
8/7/2017	Omead Ostadan	EVP	Sell	1,671	$195.26	$326,279.46	24,571
8/3/2017	Charles Dadswell	SVP	Sell	1,609	$197.00	$316,973.00	9,037
8/3/2017	Marc Stapley	EVP	Sell	2,000	$196.80	$393,600.00	37,941
8/2/2017	Jay T Flatley	Director	Sell	20,000	$176.43	$3,528,600.00	534,176
8/2/2017	Michel Bouchard	Insider	Sell	3,131	$194.97	$610,451.07	15,777
8/2/2017	Mostafa Ronaghi	SVP	Sell	10,000	$195.00	$1,950,000.00	76,585
7/18/2017	Jay T Flatley	Director	Sell	15,000	$170.77	$2,561,550.00	534,176
7/14/2017	Marc Stapley	EVP	Sell	2,000	$173.56	$347,120.00	39,941
7/7/2017	Omead Ostadan	EVP	Sell	1,672	$172.73	$288,804.56	26,242
7/5/2017	Jay T Flatley	Director	Sell	15,000	$172.92	$2,593,800.00	534,176
7/3/2017	Charles Dadswell	SVP	Sell	145	$174.24	$25,264.80	10,646
6/23/2017	Michel Bouchard	Insider	Sell	246	$185.00	$45,510.00	18,893
6/22/2017	Jay T Flatley	Director	Sell	20,000	$178.21	$3,564,200.00	534,176
6/12/2017	Marc Stapley	EVP	Sell	2,000	$170.85	$341,700.00	41,341
6/8/2017	Michel Bouchard	Insider	Sell	246	$178.91	$44,011.86	19,139
6/6/2017	Jay T Flatley	Director	Sell	20,000	$180.24	$3,604,800.00	539,176
6/5/2017	Charles Dadswell	SVP	Sell	145	$184.75	$26,788.75	10,791
6/1/2017	Jay T Flatley	Director	Sell	3,320	$180.55	$599,426.00	519,176
5/25/2017	Frances Arnold	Director	Sell	825	$174.77	$144,185.25	8,816
5/23/2017	Jay T Flatley	Director	Sell	15,000	$175.53	$2,632,950.00	534,176
5/10/2017	A Blaine Bowman	Director	Sell	2,300	$181.61	$417,703.00	18,004
5/9/2017	Jay T Flatley	Director	Sell	20,000	$184.14	$3,682,800.00	539,176
5/9/2017	Michel Bouchard	Insider	Sell	5,740	$184.68	$1,060,063.20	22,255
5/3/2017	Charles Dadswell	SVP	Sell	1,609	$187.07	$300,995.63	10,936
4/12/2017	A Blaine Bowman	Director	Sell	3,000	$172.72	$518,160.00	18,704
4/7/2017	Daniel Bradbury	Director	Sell	600	$172.79	$103,674.00	17,065
3/24/2017	Omead Ostadan	EVP	Sell	1,672	$170.00	$284,240.00	29,586
3/21/2017	Daniel Bradbury	Director	Sell	600	$163.56	$98,136.00	17,065
2/17/2017	Daniel Bradbury	Director	Sell	600	$162.80	$97,680.00	17,065
2/13/2017	Omead Ostadan	EVP	Sell	2,173	$163.10	$354,416.30
2/8/2017	A Blaine Bowman	Director	Sell	3,000	$162.74	$488,220.00	16,204
2/6/2017	Charles Dadswell	SVP	Sell	572	$161.26	$92,240.72	7,592
1/30/2017	Omead Ostadan	EVP	Sell	259	$160.90	$41,673.10	27,949
1/19/2017	Omead Ostadan	EVP	Sell	2,378	$160.06	$380,622.68	29,040
1/11/2017	A Blaine Bowman	Director	Sell	3,000	$162.89	$488,670.00	18,704
1/10/2017	Charles Dadswell	SVP	Sell	116	$161.60	$18,745.60
1/4/2017	Daniel Bradbury	Director	Sell	600	$135.01	$81,006.00	17,065
12/15/2016	Omead Ostadan	EVP	Sell	2,000	$126.16	$252,320.00
12/12/2016	Daniel Bradbury	Director	Sell	600	$123.42	$74,052.00	17,065
12/8/2016	Omead Ostadan	EVP	Sell	3,000	$121.63	$364,890.00	52,988
12/1/2016	Omead Ostadan	EVP	Sell	3,000	$133.30	$399,900.00	51,492
11/14/2016	Daniel Bradbury	Director	Sell	600	$136.34	$81,804.00	17,065
10/7/2016	Daniel Bradbury	Director	Sell	600	$184.36	$110,616.00	17,065
10/4/2016	Charles Dadswell	SVP	Sell	116	$182.38	$21,156.08	39,900
9/20/2016	Robert S Epstein	Director	Sell	300	$174.29	$52,287.00	6,924
9/15/2016	Marc Stapley	EVP	Sell	1,270	$172.87	$219,544.90	33,916
9/14/2016	Daniel Bradbury	Director	Sell	600	$171.25	$102,750.00	17,065
8/23/2016	Jay T Flatley	Director	Sell	20,000	$172.99	$3,459,800.00	508,061
8/22/2016	Robert S Epstein	Director	Sell	300	$170.27	$51,081.00	7,224
8/17/2016	Daniel Bradbury	Director	Sell	600	$168.42	$101,052.00	17,065
8/15/2016	Jay T Flatley	Director	Sell	10,000	$170.00	$1,700,000.00	498,061
8/12/2016	Roy A Whitfield	Director	Sell	4,000	$167.22	$668,880.00	6,853
8/9/2016	Jay T Flatley	Director	Sell	10,000	$165.97	$1,659,700.00	498,061
8/1/2016	Jay T Flatley	Director	Sell	10,000	$170.00	$1,700,000.00	498,061
7/27/2016	Charles Dadswell	SVP	Sell	8,632	$155.00	$1,337,960.00	40,248
7/26/2016	Jay T Flatley	Director	Sell	10,000	$150.00	$1,500,000.00	498,061
7/20/2016	Robert S Epstein	Director	Sell	1,200	$150.00	$180,000.00	7,824
7/18/2016	Jay T Flatley	Director	Sell	10,000	$150.00	$1,500,000.00	498,061
7/14/2016	A Blaine Bowman	Director	Sell	5,000	$147.14	$735,700.00	20,704
7/11/2016	Christian O Henry	EVP	Sell	716	$141.89	$101,593.24	18,976
6/16/2016	A Blaine Bowman	Director	Sell	5,000	$135.08	$675,400.00	20,704
6/15/2016	Christian O Henry	EVP	Sell	2,141	$137.90	$295,243.90	20,213
6/13/2016	Roy A Whitfield	Director	Sell	3,800	$140.44	$533,672.00	6,653
6/1/2016	Karin Eastham	Director	Sell	5,000	$145.35	$726,750.00	17,424
5/25/2016	Christian O Henry	EVP	Sell	2,141	$144.73	$309,866.93	22,463
5/17/2016	Christian O Henry	EVP	Sell	2,141	$140.84	$301,538.44	24,174
5/12/2016	A Blaine Bowman	Director	Sell	5,000	$137.11	$685,550.00	18,615
4/27/2016	Christian O Henry	EVP	Sell	2,141	$138.46	$296,442.86	27,073
4/18/2016	Christian O Henry	EVP	Sell	2,141	$176.01	$376,837.41	29,889
4/18/2016	Paul L Bianchi	VP	Sell	1,884	$175.00	$329,700.00	65,660
4/14/2016	A Blaine Bowman	Director	Sell	5,000	$172.94	$864,700.00	18,615
4/13/2016	Christian O Henry	EVP	Sell	12,500	$175.00	$2,187,500.00	42,897
4/13/2016	Paul L Bianchi	VP	Sell	6,681	$175.00	$1,169,175.00	67,544
4/12/2016	Jay T Flatley	CEO	Sell	20,000	$170.05	$3,401,000.00	508,061
4/12/2016	Roy A Whitfield	Director	Sell	4,000	$170.00	$680,000.00	5,800
4/7/2016	David R Walt	Director	Sell	4,000	$168.90	$675,600.00	635,840
4/5/2016	Christian O Henry	EVP	Sell	2,141	$166.07	$355,555.87	31,997
4/4/2016	Charles Dadswell	SVP	Sell	8,382	$167.81	$1,406,583.42	54,970
3/23/2016	Christian O Henry	EVP	Sell	2,141	$155.05	$331,962.05	33,738
3/22/2016	Jay T Flatley	CEO	Sell	10,000	$154.18	$1,541,800.00	498,061
3/21/2016	Daniel Bradbury	Director	Sell	1,200	$155.63	$186,756.00	15,576
3/21/2016	Nicholas Naclerio	SVP	Sell	4,520	$154.25	$697,210.00	30,020
3/17/2016	A Blaine Bowman	Director	Sell	5,000	$145.24	$726,200.00	18,615
3/15/2016	David R Walt	Director	Sell	4,000	$149.99	$599,960.00	635,840
3/14/2016	Christian O Henry	EVP	Sell	5,892	$155.91	$918,621.72	38,529
3/8/2016	Charles Dadswell	SVP	Sell	8,382	$155.63	$1,304,490.66	66,507
3/8/2016	Jay T Flatley	CEO	Sell	10,000	$154.49	$1,544,900.00	500,915
3/8/2016	Omead Ostadan	EVP	Sell	4,516	$156.09	$704,902.44	60,576
3/7/2016	Charles Dadswell	SVP	Sell	116	$155.00	$17,980.00	66,507
2/23/2016	Jay T Flatley	CEO	Sell	10,000	$152.49	$1,524,900.00	440,784
2/17/2016	Daniel Bradbury	Director	Sell	1,700	$154.74	$263,058.00	14,376
2/12/2016	Roy A. Whitfield	Director	Sell	3,750	$140.30	$526,125.00	1,800
2/1/2016	Omead Ostadan	EVP	Sell	1,108	$156.73	$173,656.84	46,476
1/26/2016	Jay T. Flatley	CEO	Sell	20,000	$171.70	$3,434,000.00	433,423
1/13/2016	Jay T. Flatley	CEO	Sell	20,000	$168.81	$3,376,200.00	433,423
1/4/2016	Daniel Bradbury	Director	Sell	1,700	$182.80	$310,760.00	14,376
12/28/2015	Charles Dadswell	SVP	Sell	168	$188.63	$31,689.84	41,830
12/22/2015	Jay T. Flatley	CEO	Sell	25,000	$185.38	$4,634,500.00	433,423
12/14/2015	Roy A. Whitfield	Director	Sell	3,750	$175.07	$656,512.50	13,648
12/11/2015	Omead Ostadan	EVP	Sell	260	$179.90	$46,774.00	48,293
12/11/2015	Paul L Bianchi	VP	Sell	197	$179.90	$35,440.30	59,827
12/10/2015	Daniel Bradbury	Director	Sell	1,700	$182.37	$310,029.00	14,376
12/8/2015	Jay T. Flatley	CEO	Sell	25,000	$177.11	$4,427,750.00	433,423
11/27/2015	Robert S Epstein	Director	Sell	1,000	$185.56	$185,560.00	6,935
11/25/2015	Jay T. Flatley	CEO	Sell	5,000	$180.00	$900,000.00	423,793
11/24/2015	Jay T. Flatley	CEO	Sell	20,000	$173.27	$3,465,400.00	423,793
11/16/2015	Jay T. Flatley	CEO	Sell	10,000	$170.00	$1,700,000.00	423,793
11/10/2015	Daniel Bradbury	Director	Sell	1,700	$154.03	$261,851.00	14,376
11/10/2015	Jay T. Flatley	CEO	Sell	10,000	$154.58	$1,545,800.00	423,793
11/3/2015	Charles Dadswell	SVP	Sell	158	$150.00	$23,700.00	40,847
10/15/2015	Jay T. Flatley	CEO	Sell	10,000	$150.00	$1,500,000.00	424,996
10/7/2015	Daniel Bradbury	Director	Sell	1,700	$145.81	$247,877.00	14,376
9/29/2015	David R Walt	Director	Sell	2,000	$171.65	$343,300.00	648,840
9/22/2015	Jay T. Flatley	CEO	Sell	25,000	$192.79	$4,819,750.00	424,996
9/15/2015	David R Walt	Director	Sell	2,000	$206.45	$412,900.00	648,840
9/14/2015	Daniel Bradbury	Director	Sell	1,700	$203.89	$346,613.00	14,376
9/9/2015	Paul L. Bianchi	VP	Sell	1,245	$199.32	$248,153.40	58,519
9/8/2015	Jay T. Flatley	CEO	Sell	25,000	$194.87	$4,871,750.00	424,996
9/8/2015	Karin Eastham	Director	Sell	4,300	$195.76	$841,768.00	10,419
9/4/2015	Roy A. Whitfield	Director	Sell	4,500	$192.63	$866,835.00	13,648
9/1/2015	David R Walt	Director	Sell	2,000	$195.08	$390,160.00	648,840
8/27/2015	Jay T. Flatley	CEO	Sell	25,000	$200.16	$5,004,000.00	424,996
8/18/2015	David R Walt	Director	Sell	2,000	$206.89	$413,780.00
8/17/2015	Daniel Bradbury	Director	Sell	1,700	$208.14	$353,838.00
8/13/2015	Jay T Flatley	CEO	Sell	25,000	$207.85	$5,196,250.00
8/5/2015	Roy A. Whitfield	Director	Sell	4,500	$215.22	$968,490.00	13,648
7/24/2015	A Blaine Bowman	Director	Sell	3,000	$221.47	$664,410.00
7/23/2015	Jay T Flatley	CEO	Sell	25,000	$214.87	$5,371,750.00
7/21/2015	David R Walt	Director	Sell	12,000	$235.24	$2,822,880.00
7/17/2015	Mostafa Ronaghi	SVP	Sell	1,200	$235.00	$282,000.00
7/16/2015	Christian O Henry	SVP	Sell	5,390	$229.61	$1,237,597.90
7/15/2015	Mostafa Ronaghi	SVP	Sell	3,000	$227.19	$681,570.00
7/14/2015	David R Walt	Director	Sell	10,000	$227.39	$2,273,900.00
7/13/2015	Marc Stapley	CFO	Sell	3,000	$214.90	$644,700.00
7/13/2015	Michel Bouchard	CAO	Sell	1,400	$222.75	$311,850.00
7/10/2015	Omead Ostadan	SVP	Sell	1,110	$219.81	$243,989.10
7/10/2015	Robert S Epstein	Director	Sell	2,000	$219.81	$439,620.00
7/9/2015	Jay T Flatley	CEO	Sell	25,000	$218.10	$5,452,500.00
7/7/2015	David R Walt	Director	Sell	10,000	$220.22	$2,202,200.00
7/6/2015	Daniel Bradbury	Director	Sell	1,700	$219.70	$373,490.00
6/30/2015	David R Walt	Director	Sell	10,000	$217.64	$2,176,400.00
6/25/2015	Jay T Flatley	CEO	Sell	25,000	$220.34	$5,508,500.00
6/24/2015	A Blaine Bowman	Director	Sell	3,000	$221.43	$664,290.00
6/24/2015	Christian O Henry	SVP	Sell	5,084	$221.07	$1,123,919.88
6/23/2015	David R Walt	Director	Sell	12,000	$220.11	$2,641,320.00
6/17/2015	Christian O Henry	SVP	Sell	3,751	$215.71	$809,128.21
6/16/2015	David R Walt	Director	Sell	10,000	$215.14	$2,151,400.00
6/15/2015	Nicholas Naclerio	SVP	Sell	6,590	$214.33	$1,412,434.70
6/15/2015	Paul L Bianchi	VP	Sell	3,408	$215.83	$735,548.64
6/12/2015	Marc Stapley	CFO	Sell	3,000	$214.90	$644,700.00
6/12/2015	Michel Bouchard	CAO	Sell	1,400	$216.11	$302,554.00
6/11/2015	Jay T Flatley	CEO	Sell	25,000	$216.41	$5,410,250.00
6/10/2015	Christian O Henry	SVP	Sell	10,000	$214.94	$2,149,400.00
6/10/2015	Robert S Epstein	Director	Sell	2,000	$214.24	$428,480.00
6/5/2015	Roy A Whitfield	Director	Sell	4,500	$207.49	$933,705.00
6/2/2015	David R Walt	Director	Sell	10,000	$204.42	$2,044,200.00
6/1/2015	Karin Eastham	Director	Sell	5,000	$205.24	$1,026,200.00
5/29/2015	Daniel Bradbury	Director	Sell	1,700	$206.62	$351,254.00
5/28/2015	Jay T Flatley	CEO	Sell	25,000	$208.78	$5,219,500.00
5/22/2015	A Blaine Bowman	Director	Sell	3,000	$204.58	$613,740.00
5/19/2015	David R Walt	Director	Sell	10,000	$202.00	$2,020,000.00
5/14/2015	Christian O Henry	SVP	Sell	3,751	$198.52	$744,648.52
5/14/2015	Jay T Flatley	CEO	Sell	25,000	$197.76	$4,944,000.00
5/13/2015	Paul L Bianchi	VP	Sell	3,356	$197.14	$661,601.84
5/11/2015	Robert S Epstein	Director	Sell	2,000	$196.49	$392,980.00
4/28/2015	David R Walt	Director	Sell	7,000	$183.88	$1,287,160.00
4/24/2015	A Blaine Bowman	Director	Sell	3,000	$190.73	$572,190.00
4/23/2015	Jay T Flatley	CEO	Sell	25,000	$189.57	$4,739,250.00
4/21/2015	David R Walt	Director	Sell	10,000	$197.95	$1,979,500.00
4/15/2015	Christian O Henry	SVP	Sell	3,751	$189.02	$709,014.02
4/14/2015	David R Walt	Director	Sell	7,000	$188.23	$1,317,610.00
4/13/2015	Marc Stapley	CFO	Sell	3,000	$190.12	$570,360.00
4/13/2015	Michel Bouchard	CAO	Sell	1,400	$188.61	$264,054.00
4/13/2015	Paul L Bianchi	VP	Sell	3,390	$187.22	$634,675.80
4/10/2015	Robert S Epstein	Director	Sell	2,000	$186.99	$373,980.00
4/9/2015	Jay T Flatley	CEO	Sell	25,000	$184.55	$4,613,750.00
4/8/2015	Daniel Bradbury	Director	Sell	1,700	$185.32	$315,044.00
4/7/2015	David R Walt	Director	Sell	5,000	$184.28	$921,400.00
4/6/2015	Roy A Whitfield	Director	Sell	4,600	$181.32	$834,072.00
3/26/2015	Jay T Flatley	CEO	Sell	25,000	$181.34	$4,533,500.00
3/24/2015	David R Walt	Director	Sell	5,000	$192.16	$960,800.00
3/17/2015	A Blaine Bowman	Director	Sell	3,000	$192.30	$576,900.00
3/16/2015	Gerald Moeller	Director	Sell	2,700	$193.36	$522,072.00
3/16/2015	Nicholas Naclerio	SVP	Sell	6,590	$193.94	$1,278,064.60
3/13/2015	Paul L Bianchi	VP	Sell	3,390	$186.67	$632,811.30
3/12/2015	Marc Stapley	CFO	Sell	3,314	$189.01	$626,379.14
3/10/2015	Richard Klausner	SVP	Sell	1,186	$191.75	$227,415.50
3/10/2015	Robert S Epstein	Director	Sell	3,000	$191.75	$575,250.00
2/26/2015	Jay T Flatley	CEO	Sell	25,000	$195.73	$4,893,250.00
2/12/2015	Jay T Flatley	CEO	Sell	25,000	$194.64	$4,866,000.00
2/3/2015	David R Walt	Director	Sell	7,000	$190.89	$1,336,230.00
2/2/2015	Karin Eastham	Director	Sell	10,000	$192.77	$1,927,700.00
2/2/2015	Nicholas Naclerio	SVP	Sell	15,250	$194.37	$2,964,142.50
1/27/2015	Charles Dadswell	SVP	Sell	224	$198.90	$44,553.60
1/27/2015	David R Walt	Director	Sell	4,000	$201.76	$807,040.00
1/22/2015	Jay T Flatley	CEO	Sell	25,000	$188.48	$4,712,000.00
1/20/2015	William H Rastetter	Director	Sell	16,000	$188.99	$3,023,840.00
1/15/2015	Marc Stapley	CFO	Sell	1,422	$181.62	$258,263.64
1/8/2015	Jay T Flatley	CEO	Sell	25,000	$197.62	$4,940,500.00
1/6/2015	David R Walt	Director	Sell	6,000	$188.55	$1,131,300.00
1/2/2015	Karin Eastham	Director	Sell	10,000	$185.63	$1,856,300.00
12/30/2014	David R Walt	Director	Sell	5,000	$186.95	$934,750.00
12/29/2014	Gerald Moeller	Director	Sell	8,000	$187.05	$1,496,400.00
12/26/2014	Jay T Flatley	CEO	Sell	25,000	$186.71	$4,667,750.00
12/23/2014	David R Walt	Director	Sell	7,000	$184.55	$1,291,850.00
12/16/2014	David R Walt	Director	Sell	5,000	$178.35	$891,750.00
12/15/2014	Marc Stapley	CFO	Sell	1,422	$181.09	$257,509.98
12/11/2014	Jay T Flatley	CEO	Sell	25,000	$185.79	$4,644,750.00
12/9/2014	David R Walt	Director	Sell	7,000	$186.75	$1,307,250.00
12/8/2014	Daniel Bradbury	Director	Sell	1,600	$190.14	$304,224.00
12/4/2014	Karin Eastham	Director	Sell	10,000	$191.87	$1,918,700.00
12/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$188.46	$1,884,600.00
11/26/2014	Paul L Bianchi	SVP	Sell	1,626	$189.20	$307,639.20
11/17/2014	Roy A Whitfield	Director	Sell	4,000	$178.26	$713,040.00
11/14/2014	Marc Stapley	CFO	Sell	1,422	$181.13	$257,566.86
11/13/2014	Daniel Bradbury	Director	Sell	2,100	$186.88	$392,448.00
11/13/2014	Jay T Flatley	CEO	Sell	25,000	$189.32	$4,733,000.00
11/3/2014	Michel Bouchard	CAO	Sell	631	$195.68	$123,474.08
11/3/2014	Mostafa Ronaghi	SVP	Sell	10,000	$195.66	$1,956,600.00
10/30/2014	Daniel Bradbury	Director	Sell	2,100	$191.83	$402,843.00
10/23/2014	Jay T Flatley	CEO	Sell	25,000	$189.54	$4,738,500.00
10/13/2014	Daniel Bradbury	Director	Sell	2,100	$152.03	$319,263.00
10/9/2014	Jay T Flatley	CEO	Sell	25,000	$163.49	$4,087,250.00
10/7/2014	A Blaine Bowman	Director	Sell	4,456	$159.51	$710,776.56
10/1/2014	Daniel Bradbury	Director	Sell	2,100	$158.88	$333,648.00
10/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$159.81	$1,598,100.00
9/30/2014	A Blaine Bowman	Director	Sell	5,000	$164.02	$820,100.00
9/29/2014	Gerald Moeller	Director	Sell	5,000	$164.89	$824,450.00
9/25/2014	Jay T Flatley	CEO	Sell	25,000	$164.43	$4,110,750.00
9/24/2014	Christian O Henry	SVP	Sell	20,000	$167.28	$3,345,600.00
9/23/2014	A Blaine Bowman	Director	Sell	5,000	$168.50	$842,500.00
9/16/2014	A Blaine Bowman	Director	Sell	5,000	$169.60	$848,000.00
9/15/2014	Daniel Bradbury	Director	Sell	2,100	$168.57	$353,997.00
9/15/2014	Jay T Flatley	CEO	Sell	25,000	$176.06	$4,401,500.00
9/15/2014	Marc Stapley	CFO	Sell	1,422	$169.05	$240,389.10
9/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$169.53	$339,060.00
9/9/2014	A Blaine Bowman	Director	Sell	5,000	$178.08	$890,400.00
9/3/2014	Christian O Henry	SVP	Sell	10,000	$180.59	$1,805,900.00
9/3/2014	Daniel Bradbury	Director	Sell	2,100	$179.77	$377,517.00
9/2/2014	A Blaine Bowman	Director	Sell	5,000	$179.67	$898,350.00
9/2/2014	Michel Bouchard	VP	Sell	686	$180.07	$123,528.02
9/2/2014	Mostafa Ronaghi	SVP	Sell	10,000	$179.66	$1,796,600.00
8/28/2014	Jay T Flatley	CEO	Sell	30,000	$178.98	$5,369,400.00
8/26/2014	A Blaine Bowman	Director	Sell	5,000	$179.22	$896,100.00
8/22/2014	Daniel Bradbury	Director	Sell	2,100	$172.24	$361,704.00
8/19/2014	A Blaine Bowman	Director	Sell	5,000	$171.70	$858,500.00
8/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$167.23	$334,460.00
8/15/2014	Roy A Whitfield	Director	Sell	4,000	$169.28	$677,120.00
8/13/2014	Christian O Henry	SVP	Sell	20,000	$164.66	$3,293,200.00
8/5/2014	A Blaine Bowman	Director	Sell	5,000	$159.91	$799,550.00
8/4/2014	Daniel Bradbury	Director	Sell	2,100	$159.77	$335,517.00
8/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$159.73	$1,597,300.00
7/29/2014	A Blaine Bowman	Director	Sell	5,000	$166.89	$834,450.00
7/29/2014	Christian O Henry	SVP	Sell	10,000	$167.40	$1,674,000.00
7/24/2014	Jay T Flatley	CEO	Sell	30,000	$175.43	$5,262,900.00
7/23/2014	Daniel Bradbury	Director	Sell	2,100	$177.87	$373,527.00
7/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$174.26	$348,520.00
7/14/2014	Marc Stapley	CFO	Sell	1,422	$177.59	$252,532.98
7/10/2014	Jay T Flatley	CEO	Sell	30,000	$172.56	$5,176,800.00
7/8/2014	Daniel Bradbury	Director	Sell	2,100	$172.89	$363,069.00
7/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$179.47	$1,794,700.00
6/30/2014	Gerald Moeller	Director	Sell	5,000	$178.97	$894,850.00
6/27/2014	Daniel Bradbury	Director	Sell	2,100	$171.65	$360,465.00
6/26/2014	Jay T Flatley	CEO	Sell	30,000	$170.11	$5,103,300.00
6/24/2014	Christian O Henry	SVP	Sell	10,000	$172.60	$1,726,000.00
6/16/2014	Christian O Henry	SVP	Sell	20,000	$169.73	$3,394,600.00
6/16/2014	Marc Stapley	CFO	Sell	1,422	$169.25	$240,673.50
6/12/2014	Daniel Bradbury	Director	Sell	2,100	$171.17	$359,457.00
6/12/2014	Jay T Flatley	CEO	Sell	30,000	$172.25	$5,167,500.00
6/2/2014	Karin Eastham	Director	Sell	6,000	$157.56	$945,360.00
6/2/2014	Michel Bouchard	CAO	Sell	1,491	$155.51	$231,865.41
6/2/2014	Mostafa Ronaghi	SVP	Sell	10,000	$156.93	$1,569,300.00
5/22/2014	Jay Flatley	CEO	Sell	30,000	$154.95	$4,648,500.00	381,262
5/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$141.72	$283,440.00	23,146
5/15/2014	Roy Whitfield	Director	Sell	4,000	$143.71	$574,840.00	9,196
5/14/2014	Daniel Bradbury	Director	Sell	2,100	$146.46	$307,566.00	9,924
5/14/2014	Marc Stapley	CFO	Sell	1,422	$146.94	$208,948.68	21,996
5/8/2014	Jay Flatley	CEO	Sell	30,000	$143.59	$4,307,700.00	381,262
5/2/2014	Daniel Bradbury	Director	Sell	2,100	$139.66	$293,286.00	9,924
5/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$135.91	$1,359,100.00	28,604
4/24/2014	Jay Flatley	CEO	Sell	30,000	$150.80	$4,524,000.00	381,262
4/15/2014	Daniel Bradbury	Director	Sell	2,100	$131.29	$275,709.00	9,924
4/15/2014	Nicholas Naclerio	SVP	Sell	2,000	$133.56	$267,120.00	23,146
4/14/2014	Marc Stapley	CFO	Sell	1,422	$134.80	$191,685.60	21,996
4/10/2014	Jay Flatley	CEO	Sell	30,000	$139.90	$4,197,000.00	381,262
4/4/2014	Daniel Bradbury	Director	Sell	2,100	$138.44	$290,724.00	9,924
4/1/2014	Mostafa Ronaghi	SVP	Sell	10,000	$152.41	$1,524,100.00	28,604
3/27/2014	Jay Flatley	CEO	Sell	30,000	$140.11	$4,203,300.00	381,262
3/19/2014	Daniel Bradbury	Director	Sell	2,100	$161.14	$338,394.00	9,924
3/17/2014	Gerald Moeller	Director	Sell	10,000	$161.92	$1,619,200.00	14,620
3/17/2014	Nicholas Naclerio	SVP	Sell	2,000	$163.65	$327,300.00	23,146
3/14/2014	Marc Stapley	CFO	Sell	1,422	$163.35	$232,283.70	21,996
3/13/2014	Jay Flatley	CEO	Sell	30,000	$165.96	$4,978,800.00	381,262
3/11/2014	Christian Henry	SVP	Sell	3,000	$167.16	$501,480.00	28,519
3/11/2014	Michel Bouchard	CAO	Sell	2,168	$167.21	$362,511.28	25,049
3/3/2014	Michel Bouchard	CAO	Sell	2,994	$176.81	$529,369.14	29,580
2/25/2014	Michel Bouchard	CAO	Sell	24,505	$176.13	$4,316,065.65	29,580
2/24/2014	Roy Whitfield	Director	Sell	2,000	$175.26	$350,520.00	9,196
2/18/2014	Nicholas Naclerio	SVP	Sell	2,000	$169.77	$339,540.00	25,781
2/13/2014	Jay Flatley	CEO	Sell	30,000	$160.43	$4,812,900.00	385,105
2/7/2014	Jay Flatley	CEO	Sell	5,000	$152.23	$761,150.00	398,105
1/31/2014	Marc Stapley	CFO	Sell	20,038	$151.32	$3,032,150.16	21,797
1/23/2014	Jay Flatley	CEO	Sell	30,000	$142.30	$4,269,000.00	399,509
1/9/2014	Jay Flatley	CEO	Sell	30,000	$114.77	$3,443,100.00	399,509
12/26/2013	Jay Flatley	CEO	Sell	30,000	$107.88	$3,236,400.00	399,509
12/17/2013	Gregory Heath	SVP	Sell	1,875	$102.68	$192,525.00	26,740
10/30/2013	Christian O Henry	SVP	Sell	6,000	$93.29	$559,740.00
10/30/2013	David R Walt	Director	Sell	5,000	$93.02	$465,100.00
10/28/2013	William H Rastetter	Director	Sell	20,000	$92.37	$1,847,400.00
10/24/2013	Jay T Flatley	CEO	Sell	30,000	$92.32	$2,769,600.00
10/22/2013	Nicholas Naclerio	SVP	Sell	20,000	$90.00	$1,800,000.00
10/17/2013	Gregory Heath	SVP	Sell	1,875	$82.09	$153,918.75
10/16/2013	David R Walt	Director	Sell	5,000	$82.59	$412,950.00
10/15/2013	Nicholas Naclerio	SVP	Sell	4,000	$81.32	$325,280.00
10/10/2013	Christian Henry	SVP	Sell	6,000	$77.73	$466,380.00	30,236
10/10/2013	Jay Flatley	CEO	Sell	20,000	$77.75	$1,555,000.00	399,509
10/2/2013	David R Walt	Director	Sell	5,000	$80.58	$402,900.00
9/18/2013	David Walt	Director	Sell	5,000	$83.11	$415,550.00	926,488
9/17/2013	Gregory Heath	SVP	Sell	1,875	$85.20	$159,750.00	26,740
9/16/2013	Jay Flatley	CEO	Sell	30,000	$83.27	$2,498,100.00	399,509
9/16/2013	Nicholas Naclerio	SVP	Sell	4,000	$85.00	$340,000.00	24,559
9/10/2013	Gregory Heath	SVP	Sell	1,875	$82.00	$153,750.00
9/9/2013	Paul L Bianchi	SVP	Sell	1,627	$79.03	$128,581.81
9/5/2013	Christian O Henry	SVP	Sell	9,000	$78.17	$703,530.00
9/4/2013	David R Walt	Director	Sell	5,000	$77.18	$385,900.00
9/3/2013	Nicholas Naclerio	SVP	Sell	59,000	$76.91	$4,537,690.00
9/3/2013	Roy A Whitfield	Director	Sell	2,000	$78.49	$156,980.00
8/30/2013	Mark Lewis	SVP	Sell	5,000	$78.12	$390,600.00	44,837
8/22/2013	Jay Flatley	CEO	Sell	20,000	$78.65	$1,573,000.00	399,509
8/21/2013	David Walt	Director	Sell	5,000	$78.34	$391,700.00	936,488
8/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$78.43	$156,860.00	24,559
8/8/2013	Jay Flatley	CEO	Sell	20,000	$78.07	$1,561,400.00	399,509
8/7/2013	David Walt	Director	Sell	5,000	$78.29	$391,450.00	941,488
8/2/2013	Michel Bouchard	VP	Sell	11,465	$80.64	$924,537.60
7/25/2013	Christian O Henry	SVP	Sell	11,462	$80.89	$927,161.18
7/25/2013	Jay T Flatley	CEO	Sell	20,000	$81.01	$1,620,200.00
7/24/2013	David R Walt	Director	Sell	4,600	$81.44	$374,624.00
7/24/2013	Gregory Heath	SVP	Sell	209,533	$82.00	$17,181,706.00
7/24/2013	Michel Bouchard	VP	Sell	9,789	$79.28	$776,071.92
7/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$74.50	$149,000.00
7/11/2013	Jay T Flatley	CEO	Sell	20,000	$74.90	$1,498,000.00
7/11/2013	Mostafa Ronaghi	SVP	Sell	24,000	$74.95	$1,798,800.00
7/10/2013	David R Walt	Director	Sell	5,000	$74.26	$371,300.00
7/10/2013	Michel Bouchard	VP	Sell	3,618	$74.30	$268,817.40
7/9/2013	Christian O Henry	SVP	Sell	9,000	$74.01	$666,090.00
6/27/2013	Jay T Flatley	CEO	Sell	20,000	$74.96	$1,499,200.00
6/26/2013	David R Walt	Director	Sell	5,000	$75.36	$376,800.00
6/26/2013	Michel Bouchard	VP	Sell	4,272	$75.06	$320,656.32
6/25/2013	Tristan Orpin	SVP	Sell	35,000	$71.98	$2,519,300.00
6/17/2013	Nicholas Naclerio	SVP	Sell	2,000	$68.56	$137,120.00
6/14/2013	Christian O Henry	SVP	Sell	25,959	$68.10	$1,767,807.90
6/13/2013	Jay T Flatley	CEO	Sell	20,000	$66.49	$1,329,800.00
6/13/2013	Tristan Orpin	SVP	Sell	47,667	$66.55	$3,172,238.85
6/12/2013	David R Walt	Director	Sell	5,000	$67.67	$338,350.00
6/12/2013	Michel Bouchard	VP	Sell	5,170	$68.64	$354,868.80
6/11/2013	Mostafa Ronaghi	SVP	Sell	24,000	$69.01	$1,656,240.00
6/3/2013	Karin Eastham	Director	Sell	10,000	$70.34	$703,400.00
5/31/2013	Mark L Lewis	SVP	Sell	13,000	$71.72	$932,360.00
5/30/2013	Matthew L Posard	SVP	Sell	2,836	$70.80	$200,788.80
5/29/2013	David R Walt	Director	Sell	5,000	$70.92	$354,600.00
5/29/2013	Michel Bouchard	VP	Sell	6,276	$71.02	$445,721.52
5/21/2013	Jay T Flatley	CEO	Sell	24,000	$69.39	$1,665,360.00
5/20/2013	Marc Stapley	CFO	Sell	2,843	$73.38	$208,619.34
5/15/2013	David R Walt	Director	Sell	5,000	$70.73	$353,650.00
5/15/2013	Michel Bouchard	VP	Sell	14,241	$70.71	$1,006,981.11
5/15/2013	Nicholas Naclerio	SVP	Sell	2,000	$70.72	$141,440.00
5/13/2013	Mostafa Ronaghi	SVP	Sell	24,000	$68.83	$1,651,920.00
5/10/2013	Tristan Orpin	SVP	Sell	25,000	$69.60	$1,740,000.00
5/9/2013	Jay T Flatley	CEO	Sell	20,000	$66.63	$1,332,600.00
5/7/2013	Tristan Orpin	SVP	Sell	5,000	$65.68	$328,400.00
4/8/2013	Christian Cabou	SVP	Sell	16,500	$55.00	$907,500.00
4/8/2013	Marc Stapley	CFO	Sell	9,175	$55.00	$504,625.00
4/8/2013	William H Rastetter	Director	Sell	20,000	$54.95	$1,099,000.00
3/11/2013	Marc Stapley	CFO	Sell	4,468	$53.71	$239,976.28
11/8/2012	Jay T Flatley	CEO	Sell	5,000	$47.99	$239,950.00

(Data available from 1/1/2013 forward)

Illumina (NASDAQ ILMN) News Headlines

Source:

Date	Headline
	Illumina (ILMN) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - April 19 at 11:10 AM
	Bezos-Backed Cancer Startup Wants to Raise $1 Billion www.bloomberg.com - April 19 at 10:29 AM
	Illumina (ILMN) Rating Reiterated by Barclays www.americanbankingnews.com - April 17 at 4:47 PM
	Illumina (ILMN) Upgraded to "Buy" by Zacks Investment Research www.americanbankingnews.com - April 16 at 1:21 PM
	BidaskClub Downgrades Illumina (ILMN) to Strong Sell www.americanbankingnews.com - April 16 at 9:48 AM
	Illumina (ILMN) Scheduled to Post Quarterly Earnings on Monday www.americanbankingnews.com - April 16 at 2:29 AM
	Illumina (ILMN) Rating Increased to Buy at Zacks Investment Research www.americanbankingnews.com - April 15 at 5:06 PM
	ILLUMINA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC ... www.prnewswire.com - April 14 at 6:00 PM
	Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo www.forbes.com - April 14 at 6:00 PM
	Illumina (ILMN) Upgraded at BidaskClub www.americanbankingnews.com - April 14 at 5:18 PM
	Illumina (ILMN) Upgraded at First Analysis www.americanbankingnews.com - April 14 at 11:49 AM
	JPMorgan Chase Reaffirms Overweight Rating for Illumina (ILMN) www.americanbankingnews.com - April 14 at 10:35 AM
	Illumina (ILMN) Stock Rating Reaffirmed by Cowen www.americanbankingnews.com - April 14 at 10:17 AM
	Illumina (ILMN) SVP Oene Mark Van Sells 1,400 Shares www.americanbankingnews.com - April 13 at 10:10 PM
	BidaskClub Upgrades Illumina (ILMN) to "Hold" www.americanbankingnews.com - April 13 at 11:25 AM
	KIERIN NYC - Real NYC Stories Illuminated in Fragrance www.prnewswire.com - April 12 at 7:34 PM
	Illumina (ILMN) Upgraded by Vetr to Buy www.americanbankingnews.com - April 12 at 5:07 PM
	Can Solid Overall Growth Drive Illumina's (ILMN) Q1 Earnings? finance.yahoo.com - April 12 at 3:50 PM
	Illumina (ILMN) Receives Average Recommendation of "Buy" from Analysts www.americanbankingnews.com - April 12 at 3:31 PM
	Illumina (ILMN) Given "Equal Weight" Rating at Barclays www.americanbankingnews.com - April 12 at 2:52 PM
	Can Solid Overall Growth Drive Illumina's (ILMN) Q1 Earnings? www.zacks.com - April 12 at 11:23 AM
	As Illumina moves into new Peninsula digs, it's got a surprise tenant (Video) finance.yahoo.com - April 11 at 11:04 AM
	Morgan Stanley Increases Illumina (ILMN) Price Target to $170.00 www.americanbankingnews.com - April 11 at 9:31 AM
	Illumina (ILMN) & Pacific Biosciences (PACB) Head-To-Head Comparison www.americanbankingnews.com - April 10 at 5:19 PM
	Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion ... globenewswire.com - April 10 at 10:45 AM
	Analysts Expect Illumina (ILMN) Will Post Quarterly Sales of $742.52 Million www.americanbankingnews.com - April 10 at 2:36 AM
	Illumina (ILMN) Lowered to Hold at Vetr www.americanbankingnews.com - April 9 at 4:40 PM
	$1.02 Earnings Per Share Expected for Illumina (ILMN) This Quarter www.americanbankingnews.com - April 8 at 5:18 PM
	BRIEF-Illumina Says CEO Francis Desouza's FY 2017 Total Compensation Was $8.8 Mln VS $8.4 Mln In FY 2016 www.reuters.com - April 8 at 8:48 AM
	Illumina (ILMN) Upgraded by Deutsche Bank to Buy www.americanbankingnews.com - April 6 at 10:59 AM
	Illumina (ILMN) Rating Increased to Outperform at Robert W. Baird www.americanbankingnews.com - April 5 at 2:58 PM
	Illumina (ILMN) Price Target Raised to $240.00 at Bank of America www.americanbankingnews.com - April 5 at 2:15 PM
	Contrasting Bruker (BRKR) & Illumina (ILMN) www.americanbankingnews.com - April 5 at 3:08 AM
	Illumina (ILMN) SVP Charles Dadswell Sells 116 Shares www.americanbankingnews.com - April 4 at 11:37 PM
	Illumina (ILMN) Director Sells $690,390.00 in Stock www.americanbankingnews.com - April 4 at 10:38 PM
	Illumina (ILMN) Stock Rating Upgraded by ValuEngine www.americanbankingnews.com - April 3 at 1:52 PM
	ILLUMINA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the ... www.businesswire.com - March 31 at 10:17 AM
	Illumina (ILMN) Coverage Initiated by Analysts at Evercore ISI www.americanbankingnews.com - March 30 at 8:56 PM
	Piper Jaffray Reiterates Buy Rating for Illumina (ILMN) www.americanbankingnews.com - March 30 at 10:43 AM
	Illumina (ILMN) Receives Positive Rating from Wells Fargo www.americanbankingnews.com - March 30 at 12:22 AM
	SiriusDecisions Recognizes Cisco, Huron Consulting Group, Illumina, Imprivata and Vocera as Winners of the 2018 ... www.businesswire.com - March 29 at 3:42 PM
	Deutsche Bank Analysts Give Illumina (ILMN) a $275.00 Price Target www.americanbankingnews.com - March 28 at 2:06 PM
	Illumina (ILMN) Given Hold Rating at BTIG Research www.americanbankingnews.com - March 27 at 8:34 PM
	How Did Illumina Inc’s (NASDAQ:ILMN) 22.84% ROE Fare Against The Industry? finance.yahoo.com - March 27 at 3:52 PM
	Illumina: Sequencing Profits seekingalpha.com - March 27 at 10:43 AM
	Illumina (ILMN) Upgraded to Overweight at First Analysis www.americanbankingnews.com - March 26 at 10:58 AM
	Illumina (ILMN) Stock Rating Reaffirmed by Canaccord Genuity www.americanbankingnews.com - March 26 at 9:56 AM
	Illumina (ILMN) Expected to Announce Quarterly Sales of $742.73 Million www.americanbankingnews.com - March 24 at 6:56 AM
	Zacks: Brokerages Anticipate Illumina (ILMN) to Post $1.02 EPS www.americanbankingnews.com - March 22 at 5:20 PM
	Illumina Just Hit an All-Time High: Buy, Sell, or Hold? - Motley Fool www.fool.com - March 20 at 3:52 PM

Illumina (NASDAQ:ILMN) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Illumina (NASDAQ:ILMN) Income Statement, Balance Sheet and Cash Flow Statement

Illumina (NASDAQ ILMN) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff